___

• Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin
• ; 60: 277–300. doi: 10.3322/caac.20073
• Sagar PM, Gauperaa T, Suc-Ling H, et al. An audit of the treatment of the
• cancer of the oesophagus. Gut 1994; 35: 941-5.
• Daly JM, Karnell LH, Menck HR. National Cancer Data Base report on
• esophageal carcinoma. Cancer 1996; 78: 1820-8. doi: 10.1002/
• (SICI)1097-0142(19961015)78:8<1820
• Kelsen DP, Ginsberg R, Pajak TF, et al. Chemotherapy followed by surgery
• compared with surgery alone for localized esophageal cancer. N Eng J
• Med 1998; 339:1979-84.
• Herskovic A, Martz K, Al-Sarraf MV, et al. Combined chemotherapy and
• radiotherapy compared with radiotherapy alone in patients with cancer
• of the esophagus. N Eng J Med 1992; 326: 1593-8.
• Boset JF, Gignoux M, Triboulet JP, et al. Chemoradiatherapy followed by
• surgery compared with surgery alone in squamous cell cancer of the
• esophagus. N Eng J Med 1997; 337: 161-7.
• Gebski V, Burmeister B, Smithers BM, et al. Survival benefits from
• neoadjuvant chemoradiotherapy or chemotherapy in esophageal
• carcinoma: a meta-analysis. Lancet Oncol 2007;8:226–34. doi:10.1016/
• S1470-2045(07)70039-6
• Greer SE, Goodney PP, Sutton JE, et al. Neoadjuvant chemoradiotherapy
• for esophageal carcinoma: A meta-analysis. Surgery 2005; 137:172-7.
• doi:10.1016/j.surg.2004.06.033
• Fiorica F, Di Bona D, Schepis F, et al. Preoperative chemoradiotherapy for
• oesophageal cancer: A systematic review and meta-analysis. Gut 2004;
• :925-30. doi:10.1136/gut.2003.025080
• Urschel JD, Vasan H. A meta-analysis of randomized controlled trials that
• compared neoadjuvant chemoradiation and surgery to surgery alone for
• resectable esophageal cancer. Am J Surg 2003;185:538-43.
• doi:10.1016/S0002-9610(03)00066-7
• Graham AJ, Shrive FM, Ghali WA, et al. Defining the optimal
• treatment of locally advanced esophageal cancer: A systematic review
• and decision analysis. Ann Thorac Surg 2007; 83:1257-64.
• doi:10.1016/ j.athoracsur.2006.11.061
• Coia LR, Engstrom PF, Paul AR, et al. Long-term results of infusional 5-FU,
• mitomycin-C, and radiation as primary management of esophageal
• carcinoma. Int J Radiat Oncol Biol Phys 1991;20:29-36.
• doi:10.1016/0360-3016(91)90134-P
• Wong RK, Malthaner RA, Zuraw L, et al. Cancer Care Ontario Practice
• Guidelines Initiative Gastrointestinal Cancer Disease Site Group.
• Combined modality radiotherapy and chemotherapy in nonsurgical
• management of localized carcinoma of the esophagus: a practice
• guideline. Int J Radiat Oncol Biol Phys 2003; 55:930-42. .
• doi:10.1016/S0360-3016(02)04278-5
• Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of locally
• advanced esophageal cancer: long-term follow-up of a prospective
• randomized trial (RTOG 85-01). Radiation Therapy Oncology Group
• JAMA. 1999; 281:1623-7.
• al-Sarraf M, Martz K, Herskovic A, et al. Progress report of combined
• chemoradiotherapy versus radiotherapy alone in patients with
• esophageal cancer: an intergroup study. J Clin Oncol 1997;15:277-84.
• Bedenne L, Michel P, Bouché O, et al. Chemoradiation followed by surgery
• compared with chemoradiation alone in squamous cancer of the
• esophagus: FFCD 9102. J Clin Oncol 2007; 25:1160-8. doi:
• 1200/JCO.2005.04.7118
• Walsh TN, Noonan N, Hollywood D, et al. A comparison of multimodal
• therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996;
• :462-7. doi: 10.1056/NEJM199608153350702
• Urba SG, Orringer MB, Turrisi A, et al. Randomized trial of preoperative
• chemoradiation versus surgery alone in patients with locoregional
• esophageal carcinoma. J Clin Oncol 2001;19:305-13.
• Burmeister BH, Smithers BM, Gebski V, et al. Surgery alone versus
• chemoradiotherapy followed by surgery for resectable cancer of the
• oesophagus: A randomised controlled phase III trial. Lancet Oncol
• ;6:659-68. doi:10.1016/S1470-2045(05)70288-6
• Tepper J, Krasna MJ, Niedzwiecki D, et al. Phase III trial of trimodality
• therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared
• with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol
• ;26:1086-92. Doi: 10.1200/JCO.2007.12.9593
• Minsky BD, Pajak TF, Ginsberg RJ, et al. INT 0123 (Radiation Therapy
• Oncology Group 94-05) phase III trial of combined-modality therapy for
• esophageal cancer: high-dose versus standard-dose radiation therapy. J
• Clin Oncol 2002;20:1167-74.
• Common Toxicity Criteria v.3.0. http://www.eortc.be/services/
• doc/ctc/default.htm. Erişim tarihi 16.09.2011